Literature DB >> 15009655

Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins.

Alessandra Castegna1, Visith Thongboonkerd, Jon Klein, Bert C Lynn, Yu-Lai Wang, Hitoshi Osaka, Keiji Wada, D Allan Butterfield.   

Abstract

Ubiquitin carboxyl-terminal hydrolase L-1 (UCH L-1) is a crucial enzyme for proteasomal protein degradation that generates free monomeric ubiquitin. Our previous proteomic study identified UCH L-1 as one specific target of protein oxidation in Alzheimer's disease (AD) brain, establishing a link between the effect of oxidative stress on protein and the proteasomal dysfunction in AD. However, it is unclear how protein oxidation affects function, owing to the different responses of proteins to oxidation. Analysis of systems in which the oxidized protein displays lowered or null activity might be an excellent model for investigating the effect of the protein of interest in cellular metabolism and evaluating how the cell responds to the stress caused by oxidation of a specific protein. The gracile axonal dystrophy (gad) mouse is an autosomal recessive spontaneous mutant with a deletion on chromosome 5 within the gene encoding UCH L-1. The mouse displays axonal degeneration of the gracile tract. The aim of this proteomic study on gad mouse brain, with dysfunctional UCH L-1, was to determine differences in brain protein oxidation levels between control and gad samples. The results showed increased protein oxidation in thioredoxin peroxidase (peroxiredoxin), phosphoglycerate mutase, Rab GDP dissociation inhibitor alpha/ATP synthase and neurofilament-L in the gad mouse brain. These findings are discussed with reference to the effect of specific protein oxidation on potential mechanisms of neurodegeneration that pertain to the gad mouse.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009655     DOI: 10.1046/j.1471-4159.2003.02288.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors.

Authors:  Vaishali Sinha; Gihani T Wijewickrama; R Esala P Chandrasena; Hua Xu; Praneeth D Edirisinghe; Isaac T Schiefer; Gregory R J Thatcher
Journal:  ACS Chem Biol       Date:  2010-07-16       Impact factor: 5.100

Review 2.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

Review 3.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

4.  Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.

Authors:  K Y Chu; H Li; K Wada; J D Johnson
Journal:  Diabetologia       Date:  2011-10-25       Impact factor: 10.122

Review 5.  Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease.

Authors:  Stefanie Grimm; Annika Hoehn; Kelvin J Davies; Tilman Grune
Journal:  Free Radic Res       Date:  2010-09-06

6.  In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.

Authors:  Mubeen Ahmad Ansari; Gururaj Joshi; Quanzhen Huang; Wycliffe O Opii; Hafiz Mohmmad Abdul; Rukhsana Sultana; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2006-09-08       Impact factor: 7.376

7.  Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.

Authors:  Wycliffe O Opii; Gururaj Joshi; Elizabeth Head; N William Milgram; Bruce A Muggenburg; Jon B Klein; William M Pierce; Carl W Cotman; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2006-10-20       Impact factor: 4.673

8.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

9.  Impaired mitochondrial respiration and protein nitration in the rat hippocampus after acute inhalation of combustion smoke.

Authors:  Heung M Lee; Jason Reed; George H Greeley; Ella W Englander
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-24       Impact factor: 4.219

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.